BLB&B Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

BLB&B Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,346	Closed	-$468K	–	290
2024 Q2	$468K	Hold	8,346	–	–	0.03%	183
2024 Q1	$489K	Hold	8,346	–	–	0.03%	177
2023 Q4	$450K	Hold	8,346	–	–	0.03%	175
2023 Q3	$405K	Sell	8,346 -5,016	-38%	-$267K	0.03%	168
2023 Q2	$754K	Sell	13,362 -1,520	-10%	-$83.7K	0.05%	127
2023 Q1	$803K	Buy	14,882 +1,016	+7%	+$54.1K	0.06%	120
2022 Q4	$729K	Buy	13,866 +2,458	+22%	+$125K	0.06%	129
2022 Q3	$538K	Buy	11,408 +2,016	+21%	+$105K	0.04%	145
2022 Q2	$474K	Buy	9,392 +2,090	+29%	+$114K	0.04%	158
2022 Q1	$445K	Buy	7,302 +24	+0.3%	+$1.43K	0.03%	176
2021 Q4	$479K	Hold	7,278	–	–	0.03%	171
2021 Q3	$457K	Buy	7,278 +390	+6%	+$24.9K	0.03%	194
2021 Q2	$414K	Sell	6,888 -186	-3%	-$10.8K	0.03%	190
2021 Q1	$389K	Buy	7,074 +1,902	+37%	+$105K	0.03%	185
2020 Q4	$282K	Buy	+5,172	New	+$270K	0.02%	225

Other funds holding IHI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BLB&B Advisors's IHI Position: Q3 2024 in Review

BLB&B Advisors sold out of iShares US Medical Devices ETF (IHI) in Q3 2024, closing a stake of 8,346 shares — an estimated $468K sold.

BLB&B Advisors first reported a position in IHI in Q4 2020 and held it in 15 quarters. The position peaked at $803K in Q1 2023. 555 funds tracked by Wall St. Rank hold IHI as of Q3 2024.

BLB&B Advisors reported no remaining iShares US Medical Devices ETF position as of Q3 2024 after selling out during the quarter.
BLB&B Advisors sold 8,346 iShares US Medical Devices ETF shares in Q3 2024, an estimated $468K.
BLB&B Advisors first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 15 quarters.
BLB&B Advisors's iShares US Medical Devices ETF position peaked at $803K in Q1 2023.
555 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2024.

Based on BLB&B Advisors's 13F filing for Q3 2024, filed 22 Oct 2024.